Bad Blood Business Or Blood Tv Tie In

After enemies murdered his family and plundered his empire, a legendary Mafioso emerged from prison to a fateful dilemma: Rebuild or seek revenge? Montreal godfather Vito Rizzuto sat helpless in a Colorado penitentiary while learning that unidentified assassins had killed his eldest son, and likely heir, and then murdered his father. Subsequent deaths of Vito’s loyal associates filled the news throughout hissentence. From their comfortable base in the Toronto area, the Calabrian ’Ndrangheta seemed the obvious culprits; but, as internationally bestselling crime writers Peter Edwards and Antonio Nicaso reveal in this compelling and far-reaching investigation, many unseen hands were at work. In 2012, Vito Rizzuto emerged from prison, a sixty-six-year-old man who could carefully reconstruct his crime family or damn the consequences and punish his betrayers. From the events leading to his imprisonment, through the bloodshed following his release, to his mysterious death in 2013 and morerecent efforts to continue his family’s dominance, Bad Blood is the final word in the story of a twenty-first-century criminal mastermind.

"Bestselling crime writers Peter Edwards and Antonio Nicaso reveal the final years of Canada's top mafia boss, Vito Rizzuto, and his bloody war to avenge his family and control the North American drug trade. Until Vito Rizzuto went to prison in 2006 for his role in a decades-old Brooklyn triple murder, he ruled the Port of Montreal, the northern gateway to the major American drug markets. A master diplomat, he won the respect of rival mafia clans, bikers and street gangs, and criminal business thrived on his turf. His family prospered and his empire grew--until one of North America's true Teflon dons finally lost his veneer. As he watched helplessly from his Colorado prison, the murders of his son and father made international headlines; the killings of his lieutenants and friends filled the pages of Canadian news; and the influence of the 'Ndrangheta, the Calabrian Mafia, spread across Montreal faster than the blood of Rizzuto's crime family. In 2012, Vito Rizzuto emerged from prison, a 66-year-old man who could carefully rebuild his criminal empire or seek bloody revenge and damn the consequences. From the events leading to his imprisonment to his shocking death in December 2013, Business or Blood is the final chapter of Vito's story."--

"Bad things can happen when you get between a man and his gold." Jeremiah Tucker finds that surviving in the lawless American West of the 1800s is not as easy as it used to be. Together with his friend, Skeeter, they discover that trouble is right on their heels. One day, Jeremiah might be able to enjoy his gold--but that is only if he lives long enough. Don't miss this explosive episode! Bad Blood is written in the tradition of the classic American western cliffhangers. The story is set in Utah at the close of the Indian wars; giving us a glimpse into the uncomfortable and perilous relationships that existed between Americans and American Indians at the time. It is a story that deals with true friendship and trust; camaraderie and corruption.

Winner of the Financial Times and McKinsey Business Book of the Year Award 2018"You will not want to put this riveting, masterfully reported book down. No matter how bad you think the Theranos story was, you'll learn that the reality was actually far worse." Bethany McLean, bestselling coauthor of The Smartest Guys in the Room and All the Devils Are Here A New York Times bestseller to be adapted into a film with Jennifer Lawrence to star. In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup 'unicorn' promised to revolutionize the medical industry with a machine that would make blood tests significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: the technology didn't work.For years, Holmes had been misleading investors, FDA officials, and her own employees. When Carreyrou, working at the Wall Street Journal, got a tip from a former Theranos employee and started asking questions, both Carreyrou and the Journal were threatened with lawsuits. Undaunted, the newspaper ran the first of dozens of Theranos' articles in late 2015. By early 2017, the company's value was zero and Holmes faced potential legal action from the government and her investors.In Bad Blood John Carreyrou tells the story of Theranos, and encourages us to consider the possible repercussions of our blind faith in a small group of brilliant individuals. PRAISE FOR BAD BLOOD"A dazzling story of deception in Silicon Valley. . .It is a tale of heroic cupidity on a scale that made the very best and the very brightest look like the very, very foolish . . . You will not be able to put this book down." Washington Post"Chilling . . . Reads like a West Coast version of All the President's Men." New York Times Book Review"Carreyrou presents the scientific, human, legal and social sides of the story in full. Although some of it was previously reported in his extensive coverage, he unveils many dark secrets of Theranos that have not previously been laid bare." Nature"His [Carreyrou's] unmasking of Theranos is a tale of David and Goliath." Financial Times